Jonathan Young - Oct 2, 2023 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Signature
/s/ Jonathan Young
Stock symbol
AKRO
Transactions as of
Oct 2, 2023
Transactions value $
-$14,700
Form type
4
Date filed
10/4/2023, 08:33 PM
Previous filing
Sep 25, 2023
Next filing
Nov 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKRO Common Stock Options Exercise $10.3K +490 +0.27% $21.10 184K Oct 2, 2023 Direct F1
transaction AKRO Common Stock Sale -$25K -490 -0.27% $51.10 183K Oct 2, 2023 Direct F1
holding AKRO Common Stock 20K Oct 2, 2023 By EA Irrevocable Trust F2
holding AKRO Common Stock 20K Oct 2, 2023 By CM Irrevocable Trust F2
holding AKRO Common Stock 20K Oct 2, 2023 By JL Irrevocable Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKRO Stock Option (Right to Buy) Options Exercise $0 -490 -0.56% $0.00 86.7K Oct 2, 2023 Common Stock 490 $21.10 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 15, 2023, previously adopted by the reporting person.
F2 These shares are held in irrevocable trusts for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3 The options are vested and currently exercisable.